UNA - Unilever PLC
AMS
->
Consumer Defensive
->
Household & Personal Products
London,
United Kingdom
Type: Equity
UNA price evolution
UNA
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4970 | $4970 | $4159 | $4159 |
| Short term investments | $896 | $896 | $1112 | $1112 |
| Net receivables | $8093 | $8093 | $6202 | $5031 |
| Inventory | $5621 | $5621 | $5119 | $5119 |
| Total current assets | $20221 | $20221 | $17902 | $17902 |
| Long term investments | $1294 | $1294 | $1220 | $1220 |
| Property, plant & equipment | $11098 | $11098 | $10707 | $10707 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $79832 | $79832 | $75266 | $75266 |
| Current liabilities | ||||
| Accounts payable | $17160 | $17160 | $16857 | $10355 |
| Deferred revenue | ||||
| Short long term debt | $7643 | $7643 | $5087 | $5087 |
| Total current liabilities | $26130 | $26130 | $23507 | $23507 |
| Long term debt | $24011 | $24011 | $24535 | $24535 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $56809 | $56809 | $57164 | $54502 |
| Shareholders' equity | ||||
| Retained earnings | $49567 | $49567 | -$34830 | $47052 |
| Other shareholder equity | -$79476 | -$79476 | -$72979 | -$72979 |
| Total shareholder equity | $23023 | $23023 | $20764 | $20764 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2862 | $4326 | $2505 | $2764 |
| Short term investments | $1112 | $772 | $1105 | |
| Net receivables | $5686 | $7348 | $5254 | $4810 |
| Inventory | $5119 | $5931 | $4683 | $4462 |
| Total current assets | $17902 | $19157 | $17401 | $16157 |
| Long term investments | $1220 | $904 | $1063 | |
| Property, plant & equipment | $10707 | $10770 | $10347 | $10570 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $75266 | $77821 | $75095 | $67659 |
| Current liabilities | ||||
| Accounts payable | $10355 | $17870 | $8896 | $8375 |
| Deferred revenue | ||||
| Short long term debt | $5087 | $5775 | $7252 | |
| Total current liabilities | $23507 | $25427 | $24778 | $20592 |
| Long term debt | $23692 | $23713 | $22611 | $22481 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $57164 | $56120 | $57988 | $52393 |
| Shareholders' equity | ||||
| Retained earnings | -$26831 | $50253 | -$26882 | -$50997 |
| Other shareholder equity | -$2150 | -$81488 | -$6043 | -$7068 |
| Total shareholder equity | $20764 | $21701 | $19746 | |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15558.5 | $15558.5 | $29176 | $14588 |
| Cost of revenue | $17214.5 | |||
| Gross Profit | $15558.5 | $15558.5 | -$2626.5 | |
| Operating activities | ||||
| Research & development | $474.5 | |||
| Selling, general & administrative | -$17.5 | -$17.5 | $7592 | |
| Total operating expenses | $12497 | $12497 | $24453 | $12191.5 |
| Operating income | $3061.5 | $3061.5 | $2396.5 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $775 | $775 | $814 | $407 |
| Interest expense | -$305 | -$305 | -$186 | -$279 |
| Net income | ||||
| Net income | $1850.5 | $1850.5 | $2939 | $1469.5 |
| Income (for common shares) | $1850.5 | $1850.5 | $1469.5 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $59604 | $60073 | $52444 | $50724 |
| Cost of revenue | ||||
| Gross Profit | $60073 | $22185 | $22040 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | -$44 | |||
| Total operating expenses | $49673 | $50348 | $12549 | $12673 |
| Operating income | $9725 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $2199 | $2068 | $1935 | $1923 |
| Interest expense | -$387 | -$818 | -$72 | -$318 |
| Net income | ||||
| Net income | $6487 | $7642 | $6049 | $5581 |
| Income (for common shares) | $7642 | |||
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $1850.5 | $1850.5 | $1469.5 | $1469.5 |
| Operating activities | ||||
| Depreciation | $397 | $397 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1682 | $1682 | ||
| Investing activities | ||||
| Capital expenditures | -$308.5 | -$308.5 | ||
| Investments | ||||
| Total cash flows from investing | -$196 | -$196 | ||
| Financing activities | ||||
| Dividends paid | -$1068 | -$1068 | ||
| Sale and purchase of stock | -$187.5 | -$187.5 | ||
| Net borrowings | $689 | $689 | ||
| Total cash flows from financing | -$1077 | -$1077 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | $404.5 | $404.5 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | $6487 | $7642 | ||
| Operating activities | ||||
| Depreciation | $1725 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $7282 | |||
| Investing activities | ||||
| Capital expenditures | -$1627 | |||
| Investments | ||||
| Total cash flows from investing | $2453 | -$3246 | -$1481 | |
| Financing activities | ||||
| Dividends paid | -$4329 | -$4483 | -$4279 | |
| Sale and purchase of stock | -$1509 | |||
| Net borrowings | -$1727 | |||
| Total cash flows from financing | -$8890 | -$7099 | -$5804 | |
| Effect of exchange rate | $285 | -$414 | ||
| Change in cash and equivalents | $838 | -$2088 | $1359 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $74.88B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $8.11B |
| Revenue Q/Q | 2.26% |
| Revenue Y/Y | 23.00% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 10.46% |
| ROE | 37.04% |
| Debt/Equity | 2.75 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.77 |
| Quick ratio | 0.56 |